Related Experiment Video
Updated: Jun 29, 2025

07:10
Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
14.4K
High affinity mAb infusion can enhance maximum affinity maturation during HIV Env immunization
Peter Thomas1,2, Chloe Rees-Spear1, Sarah Griffith1
1Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
Iscience
|March 29, 2024
Summary
Infusing high-affinity antibodies can suppress most B cell responses but surprisingly enhances affinity maturation in specific B cell populations. This suggests a targeted approach to boost antibody responses against pathogens like HIV.
Area of Science:
- Immunology
- Vaccinology
- Molecular Biology
Background:
- Antigen-specific antibody infusion's effect on germinal center (GC) responses varies with antibody affinity.
- Understanding how antibody affinity influences B cell selection is crucial for vaccine development and immunotherapy.
Purpose of the Study:
- To investigate if escalating monoclonal antibody (mAb) affinity during immunization enhances B cell affinity maturation.
- To determine the impact of CD4 binding-site (CD4bs)-specific mAb infusion on B cell responses to HIV envelope gp120.
Main Methods:
- Mice were immunized with HIV envelope gp120.
- Mice received infusions of CD4bs-specific monoclonal antibodies (mAbs) with escalating affinity.
- Somatic hypermutation (SHM) and B cell affinity were analyzed using high-throughput sequencing of plasma cells.
Main Results:
- While most CD4bs-specific B cells showed reduced SHM and affinity, a subset exhibited increased SHM and affinity.
- Plasma cells from mAb-infused mice displayed elevated SHM.
- Phylogenetic analysis indicated accelerated differentiation in CD4bs-specific plasma cells.
Conclusions:
- High-affinity mAb infusion primarily suppresses most competing B cells.
- However, it can selectively increase and expedite affinity maturation in specific epitope-targeted B cell populations.
- This finding has implications for designing immunotherapies and vaccines.
Related Concept Videos
Hybridoma Technology
14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
Affinity and Avidity
36.0K
Overview
36.0K

